Wonik Holdings acquires 23.27% of Carelabs for KRW 62bn

SI Bio & Healthcare Digital healthcare platforms
Deal value
$43m
Stake
23.27%
Implied 100%
$184m

Deal value ÷ stake (structure unconfirmed)

Revenue
$60m

2022 연결 · DART-verified

Op. income
-$4m

2022 연결 · DART-verified

Multiples
PSR 3.0x

On implied equity value

DART 20230321000805

Target
Carelabs · Digital healthcare platforms
Buyer
Wonik Holdings · SI
Seller
—
Structure
—
Announced
Jan 18, 2023
Closed
Jan 18, 2023
Stage
Closed

Target

Carelabs is a KOSDAQ-listed digital health and beauty-care company operating the hospital-booking platform Goodoc and the aesthetic medicine platform Babitalk, along with healthcare media businesses.

Deal rationale

Wonik Holdings said it adopted digital health and beauty care as a future growth business, with global expansion as the first step, citing its group's medical-device heritage and healthcare network to help Goodoc and Babitalk grow overseas. Carelabs CEO Shin Jong-hyun said the businesses and Wonik's network would generate strong synergies. Reports said the sale process ran about two months and valued Carelabs at roughly KRW 270 billion.

신사업 진출해외 진출
Revenue$60m
Operating income-$4m
EBITDA—
Net income—

2022 연결 · DART-verified · 20230321000805

Press coverage

  • 이데일리 (2023-01-18): “총 620억원을 투자해 케어랩스 지분 23.27%를 확보했다.”
  • 아시아경제 CORE (2023-01-18): “매각 과정에서 평가된 케어랩스의 기업가치는 약 2700억원”

This is a data entry summarising filings and press reports. Please check the original sources for the figures.